Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a software or content revision. This update is a metadata change and does not modify the study details presented on the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision indicator has been updated to a newer site/software version (from v3.5.2 to v3.5.3), without changing the displayed study details.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check66 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a background site maintenance update and does not modify study content.SummaryDifference0.1%

- Check102 days agoChange DetectedAdded Revision: v3.4.2 and removed the older maintenance notices (including Revision: v3.4.1) as part of a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.